I am an inventor, entrepreneur, and creative problem solver with more than 20 years of experience developing and commercializing lab-on-a-chip devices, instrumentation, and immunoassays for in vitro diagnostic applications. My contributions to science are directly relevant to the proposed work, where I have spent more than two decades developing point-of-care lab-on-a-chip devices for a variety of in vitro diagnostic applications, including drug testing, with a particular focus on salivary diagnostics. My work resulted in more than 20 scientific papers, 6 patents, and has formed the technology base of four startup companies (Lab Now, SensoDx, Oraliva, and most recently, Portable Diagnostic Systems). I founded Portable Diagnostic Systems out of a desire to improve public health and society in a meaningful way. Our novel lab-on-a-chip technology facilitates recirculation of fluid over a sensor that is key to detecting analytes in very low volumes (<20 µL) of biological fluid with high accuracy and precision. This revolutionary technology will usher in a new era of onsite diagnostic testing that will make vital healthcare information more affordable and accessible.
Did you know?
Miranda Wang and Jeanny Yao have an uncanny talent for finding value where others see waste. Their plastics upcycling company, Novoloop, just raised an $21m Series A to prove it.
To find the future of food, you may have to look no further than Emeryville, CA, a small city by the San Francisco Bay, where Upside Foods has built a 53,000-square-foot production facility for cultivated meat, the first of its kind.
In a timeless dilemma for new parents, Radhika and her husband Bharath discovered early that their baby daughter was a fussy sleeper. The situation left them tired and frustrated; being effective at work became a challenge.
The question for Sumit Sinha and Mukesh Bansal in February 2019 was which would come first: The funding for their seed round or the sale of their Hyundai hatchbacks.
In December 2021 Prellis raised a $14.5 million Series B and has signed partnerships with pharmaceutical behemoths including Bristol Myers Squibb and Sanofi.
It was 2016, and Chiu Chau was on the ropes. He had pitched nearly 150 venture capital firms. No one would invest. Everyone doubted the startup with the open-source laboratory robot.
Tesh Mbaabu rarely showed up to his freshman computer science class at the University of Nairobi. His classmate Mesongo Sibuti noticed.
Adebayo (“Ade”) Alonge and Amy Kao, co-founders of RxAll had nvented a handheld scanner for detecting counterfeit prescription drugs—an illicit, multibillion-dollar industry that kills an estimated 1 million people annually globally and 100,000 in Africa.